Silvia Taylor | SVP, Global Corporate Affairs & IR |
Stanley Erck | President, CEO & Director |
John Trizzino | EVP & Chief Business & Commercial Officer |
Filip Dubovsky | EVP & Chief Medical Officer |
James Kelly | EVP, CFO & Treasurer |
Jiale Song | Jefferies |
Charles Duncan | Cantor Fitzgerald & Co. |
Georgi Yordanov | Cowen and Company |
Mayank Mamtani | B. Riley Securities |
Eric Joseph | JPMorgan Chase & Co. |
David Risinger | SVB Leerink Holdings |
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Conference Call. [Operator Instructions]. Please also be advised that today's conference call is being recorded. I would now like to hand the conference call over to your speaker today, Silvia Taylor.
You may begin.